Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000914541 | SCV001059721 | likely benign | not provided | 2021-08-04 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002502758 | SCV002798484 | likely benign | Focal segmental glomerulosclerosis 3, susceptibility to | 2021-10-12 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003902934 | SCV004727010 | likely benign | CD2AP-related disorder | 2019-08-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |